KAZIA THERAPEUTICS LIMITED.
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
Preclinical Studies Justify Mode of Delivery and Dosing Regimen for Anisina 2015-11-11 06:40
Novogen Applies for Long-term Options Listing 2015-09-30 10:52
Novogen Announces The Outcome Of A Comprehensive Science Review 2015-08-31 07:00
Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 2015-07-30 08:08
Novogen Appoints Iain Ross as Acting CEO and Re-appoints Him to the Board 2015-07-22 10:34
Anisina Receives Orphan Drug Designation from FDA for Neuroblastoma 2015-07-16 15:37
Pre-clinical Studies Suggest Anisina May Improve Chemotherapy Effectiveness in Childhood Cancer 2015-07-14 07:00
Novogen Announces the Chairman's Address at the Company's General Meeting 2015-06-24 10:54
Anisina on Track to Enter Clinic in 2016 2015-06-24 08:00
Novogen to Present at Bio International Convention Philadelphia 2015 2015-06-12 12:15
Studies Confirm TRXE-009 Crosses the Blood-brain Barrier 2015-06-05 07:30
Studies Confirm TRXE-009 Crosses the Blood-brain Barrier 2015-06-04 20:00
Novogen Expands Board with Two New Appointments 2015-06-03 09:20
Novogen Limited Announces Closing of Rights Issue Entitlement Offer and Notice of Shortfall 2015-06-02 11:47
ATM Technology Extended with New Patent Lodgement 2015-05-28 10:02
Novogen to Present at Brain Tumor Biotech Summit 2015 2015-05-27 06:00
Novogen to Present at the 2015 Marcum Microcap Conference 2015-05-26 08:28
Novogen to Present at Hong Kong Investor Conference 2015-05-18 09:08
Anisina Confirmed as Effective Anti-Cancer Agent in Animal Studies 2015-05-14 09:39
Australian Studies Confirm TRXE-009 Kills Resistant Paediatric Brain Cancer Cells 2015-05-08 06:54
1 3 4 5 6 7